Clinical Utility of Methylation-based Prognostic Assay for Barrett's Esophagus
Clinical trial NCT05846971 · UNKNOWN
Trial details
- NCT number
- NCT05846971
- Sponsor
- Capsulomics, Inc.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-26
- Primary completion
- 2023-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.